Nanoform Finland Oyj (STO:NANOFS)
Sweden
· Delayed Price · Currency is SEK 10.26
-0.24 (-2.29%)
At close: May 9, 2025
Nanoform Finland Oyj Revenue
In the year 2024, Nanoform Finland Oyj had annual revenue of 3.66M EUR with 42.70% growth. Nanoform Finland Oyj had revenue of 1.64M in the quarter ending December 31, 2024, with 308.35% growth.
Revenue
3.66M EUR
Revenue Growth
+42.70%
P/S Ratio
21.31
Revenue / Employee
20.23K EUR
Employees
181
Market Cap
894.09M SEK
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |